Very informative.. Is this another reason ELTP continues to dilute shareholders and new shares are entering the market by the millions suffocating the share price?
There are no buyer coming in as volume is anemic. It is obvious that SequestOx will not get Abuse deterrent labeling. FDA is clear when they denied KMPH abuse deterrent labeling. Any technology that does not address core issue of addiction through ingestion will not be allowed ADL. Insurance companies will not reimburse without ADL. ELTP will crash without Abuse deterrent labeling same as KMPH. ELTP is just another company that claim Abuse deterrent technology without solving the main problem, Opioid Ingestion.
I was hearing similar feelings from experts in the field.
Explains why institutions wont touch ELTP (0.2% ownership)and shares struggle on a daily basis within a couple cent spread
Something is very wrong here. Smart people recognize this.
Market Data 
Markets 
AI
